Serum Institute Of India Pvt. Ltd.
Clinical trials sponsored by Serum Institute Of India Pvt. Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Next-Generation polio vaccine enters human testing Results expected Nov 2026 (estimated)
- 5 years later: does one meningitis shot still shield? Results expected Dec 2026 (estimated)
- HPV vaccine trial aims to protect women with HIV from cervical cancer Results expected Dec 2026 (estimated)
-
Could a Lower-Dose polio vaccine help eradicate the disease?
Vaccine CompletedThis study tests a hexavalent vaccine that protects against six diseases, including polio, but uses a lower dose of the inactivated polio vaccine (IPV). The goal is to see if this reduced-dose version works as well as the standard full-dose vaccine in infants. Around 1,500 health…
Phase 3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Vaccine
Last updated Jul 03, 2026 00:00 UTC
-
New malaria vaccine combo shows promise in early trial
Vaccine CompletedThis Phase 1 trial tested a new malaria vaccine that combines two different vaccine components (Pfs230D1 and R21) with an immune-boosting adjuvant called Matrix-M. The study involved 240 healthy adults aged 18 to 50 in Africa. The main goal was to check the vaccine's safety and h…
Phase 1 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 09:03 UTC